Biotech · Private company
LEO Pharma
Track this companyFree. Adds LEO Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials257 recruiting or active
Pipeline programs28From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline28
- Cream VehiclePhase 3 · Lichen SclerosusClinicalTrials.gov · fetched Nov 12, 2026
- DelgocitinibPhase 3 · Lichen SclerosusClinicalTrials.gov · fetched Nov 12, 2026
- ingenol disoxate gel 0.018%Phase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- ingenol disoxate gel 0.037%Phase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- Matching VehiclePhase 3 · IchthyosisClinicalTrials.gov · fetched Nov 12, 2026
- PrednisolonePhase 3 · Pyoderma GangrenosumClinicalTrials.gov · fetched Nov 12, 2026
- PrednisonePhase 3 · Pyoderma GangrenosumClinicalTrials.gov · fetched Nov 12, 2026
- SpesolimabPhase 3 · Pyoderma GangrenosumClinicalTrials.gov · fetched Nov 12, 2026
- TMB-001Phase 3 · IchthyosisClinicalTrials.gov · fetched Nov 12, 2026
- TralokinumabPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Tralokinumab + TCSPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle gelPhase 3 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- 2% TD1414 CreamPhase 2 · Secondarily Infected Traumatic Lesions (SITL)ClinicalTrials.gov · fetched Nov 12, 2026
- Bactroban® (mupirocin) 2% creamPhase 2 · ImpetigoClinicalTrials.gov · fetched Nov 12, 2026
- Calcipotriene plus betamethasone dipropionate ointmentPhase 2 · Psoriasis VulgarisClinicalTrials.gov · fetched Nov 12, 2026
- Delgocitinib creamPhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Delgocitinib creamPhase 2 · Palmoplantar PustulosisClinicalTrials.gov · fetched Nov 12, 2026
- Delgocitinib creamPhase 2 · Chronic Hand EczemaClinicalTrials.gov · fetched Nov 12, 2026
- Delgocitinib cream vehiclePhase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Delgocitinib cream vehiclePhase 2 · Chronic Hand EczemaClinicalTrials.gov · fetched Nov 12, 2026
- Ingenol mebutate gelPhase 2 · Actinic KeratosisClinicalTrials.gov · fetched Nov 12, 2026
- IsotretinoinPhase 2 · Congenital IchthyosisClinicalTrials.gov · fetched Nov 12, 2026
- LEO 138559Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- LEO 80185 (Taclonex® Scalp topical suspension/Xamiol® gel)Phase 2 · Scalp PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- SpesolimabPhase 2 · Generalized Pustular PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- TD1414 2% creamPhase 2 · ImpetigoClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Congenital IchthyosisClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle creamPhase 2 · Palmoplantar PustulosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen PlanopilarisPHASE2 · RECRUITING · started May 19, 2026ClinicalTrials.gov NCT07487948 · fetched Nov 12, 2026
- A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen SclerosusPHASE3 · RECRUITING · started May 1, 2026ClinicalTrials.gov NCT07335588 · fetched Nov 12, 2026
- A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisPHASE2 · RECRUITING · started Sep 11, 2025ClinicalTrials.gov NCT07013201 · fetched Nov 12, 2026
- A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumPHASE3 · RECRUITING · started Feb 5, 2025ClinicalTrials.gov NCT06624670 · fetched Nov 12, 2026
- A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic DermatitisPHASE3 · RECRUITING · started Jun 10, 2024ClinicalTrials.gov NCT06311682 · fetched Nov 12, 2026
- A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated FlaresPHASE4 · COMPLETED · started Oct 22, 2023ClinicalTrials.gov NCT06013969 · fetched Nov 12, 2026
- A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic DermatitisPHASE2 · COMPLETED · started Sep 20, 2023ClinicalTrials.gov NCT05923099 · fetched Nov 12, 2026
- Tralokinumab for Dupilumab FailuresPHASE4 · TERMINATED · started Sep 11, 2023ClinicalTrials.gov NCT06773455 · fetched Nov 12, 2026
- A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic TherapyPHASE3 · COMPLETED · started Aug 28, 2023ClinicalTrials.gov NCT05958407 · fetched Nov 12, 2026
- Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECTRECRUITING · started Dec 8, 2022ClinicalTrials.gov NCT05938478 · fetched Nov 12, 2026
- The ASCEND Study: Evaluating TMB-001 in the Treatment of RXLI or ARCI IchthyosisPHASE3 · COMPLETED · started Jun 21, 2022ClinicalTrials.gov NCT05295732 · fetched Nov 12, 2026
- An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.PHASE2 · COMPLETED · started Jul 14, 2021ClinicalTrials.gov NCT04922021 · fetched Nov 12, 2026
- A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital IchthyosisPHASE2 · COMPLETED · started Dec 3, 2019ClinicalTrials.gov NCT04154293 · fetched Nov 12, 2026
- Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous StudyPHASE2 · ACTIVE_NOT_RECRUITING · started May 29, 2019ClinicalTrials.gov NCT03886246 · fetched Nov 12, 2026
- Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.PHASE2 · COMPLETED · started Dec 28, 2018ClinicalTrials.gov NCT03725722 · fetched Nov 12, 2026
- Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand EczemaPHASE2 · COMPLETED · started Nov 28, 2018ClinicalTrials.gov NCT03683719 · fetched Nov 12, 2026
- Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3PHASE3 · COMPLETED · started Feb 22, 2018ClinicalTrials.gov NCT03363854 · fetched Nov 12, 2026
- A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or ScalpPHASE3 · TERMINATED · started Jun 16, 2017ClinicalTrials.gov NCT03115476 · fetched Nov 12, 2026
- Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)PHASE3 · COMPLETED · started Jun 12, 2017ClinicalTrials.gov NCT03160885 · fetched Nov 12, 2026
- Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 1 (ECZema TRAlokinumab Trial no. 1)PHASE3 · COMPLETED · started May 30, 2017ClinicalTrials.gov NCT03131648 · fetched Nov 12, 2026
- Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic KeratosisPHASE1_PHASE2 · COMPLETED · started Apr 1, 2013ClinicalTrials.gov NCT01820260 · fetched Nov 12, 2026
- Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp PsoriasisPHASE2 · COMPLETED · started Apr 1, 2010ClinicalTrials.gov NCT01083758 · fetched Nov 12, 2026
- Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis VulgarisPHASE2 · COMPLETED · started Jul 1, 2009ClinicalTrials.gov NCT00817219 · fetched Nov 12, 2026
- The Pharmacokinetics of 2% TD1414 Cream in Adults With Secondarily Infected Traumatic Lesions (SITL) or ImpetigoPHASE2 · COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00758862 · fetched Nov 12, 2026
- Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)PHASE2 · COMPLETED · started Feb 1, 2008ClinicalTrials.gov NCT00626795 · fetched Nov 12, 2026